3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) |
A substituted cathinone that is structurally analogous to methylone, a nar… |
10 mg |
9001330-10 |
More Info
|
3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) |
A substituted cathinone that is structurally analogous to methylone, a nar… |
5 mg |
9001330-5 |
More Info
|
3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) |
A substituted cathinone that is structurally analogous to methylone, a nar… |
50 mg |
9001330-50 |
More Info
|
Methylenedioxynitazene (citrate) |
An analytical reference standard categorized as a nitazene; intended for r… |
1 mg |
38843-1 |
More Info
|
Methylenedioxynitazene (citrate) |
An analytical reference standard categorized as a nitazene; intended for r… |
5 mg |
38843-5 |
More Info
|
3,4-methylenedioxy PCP (hydrochloride) |
An analytical reference standard categorized as an arylcyclohexylamine; in… |
1 mg |
35352-1 |
More Info
|
3,4-methylenedioxy PCP (hydrochloride) |
An analytical reference standard categorized as an arylcyclohexylamine; in… |
5 mg |
35352-5 |
More Info
|
3,4-Methylenedioxyphenmetrazine (hydrochloride) |
An analytical reference standard that is structurally similar to known sti… |
1 mg |
38615-1 |
More Info
|
3,4-Methylenedioxypropiophenone |
An analytical reference standard categorized as a precursor in the synthes… |
10 mg |
39438-10 |
More Info
|
3,4-Methylenedioxypropiophenone |
An analytical reference standard categorized as a precursor in the synthes… |
50 mg |
39438-50 |
More Info
|
3,4-Methylenedioxy PV9 (hydrochloride) |
A cathinone whose physiological and toxicological properties are not known |
1 mg |
16359-1 |
More Info
|
3,4-Methylenedioxy PV9 (hydrochloride) |
A cathinone whose physiological and toxicological properties are not known |
10 mg |
16359-10 |
More Info
|
3,4-Methylenedioxy PV9 (hydrochloride) |
A cathinone whose physiological and toxicological properties are not known |
5 mg |
16359-5 |
More Info
|
3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) |
An internal standard for the quantification of 3,4-MDPV by GC- or LC-MS |
1 mg |
10679-1 |
More Info
|
3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) |
An internal standard for the quantification of 3,4-MDPV by GC- or LC-MS |
10 mg |
10679-10 |
More Info
|
3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) |
An internal standard for the quantification of 3,4-MDPV by GC- or LC-MS |
5 mg |
10679-5 |
More Info
|
(+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; reguated as a Schedule 1 comp… |
1 mg |
14524-1 |
More Info
|
(+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; reguated as a Schedule 1 comp… |
10 mg |
14524-10 |
More Info
|
(+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; reguated as a Schedule 1 comp… |
5 mg |
14524-5 |
More Info
|
2,3-Methylenedioxy Pyrovalerone (hydrochloride) |
A potential psychoactive designer drug structurally related to 3,4-MDPV; i… |
10 mg |
9001051-10 |
More Info
|
2,3-Methylenedioxy Pyrovalerone (hydrochloride) |
A potential psychoactive designer drug structurally related to 3,4-MDPV; i… |
5 mg |
9001051-5 |
More Info
|
2,3-Methylenedioxy Pyrovalerone (hydrochloride) |
A potential psychoactive designer drug structurally related to 3,4-MDPV; i… |
50 mg |
9001051-50 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
1 mg |
10518-1 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
10 mg |
10518-10 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
5 mg |
10518-5 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
1 mg |
12004-1 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
10 mg |
12004-10 |
More Info
|
3,4-Methylenedioxy Pyrovalerone metabolite 2 (hydrochloride) |
A metabolite produced during phase I metabolism of 3,4-MDPV |
5 mg |
12004-5 |
More Info
|
3,4-Methylenedioxy U-47700 (hydrochloride) |
An analytical reference standard structurally similar to known opioids; in… |
1 mg |
22753-1 |
More Info
|
3,4-Methylenedioxy U-47700 (hydrochloride) |
An analytical reference standard structurally similar to known opioids; in… |
5 mg |
22753-5 |
More Info
|
4-methyl Erlotinib |
An erlotinib analog characterized by the addition of a methyl group at the… |
1 mg |
9001510-1 |
More Info
|
4-methyl Erlotinib |
An erlotinib analog characterized by the addition of a methyl group at the… |
10 mg |
9001510-10 |
More Info
|
4-methyl Erlotinib |
An erlotinib analog characterized by the addition of a methyl group at the… |
5 mg |
9001510-5 |
More Info
|
2-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; intended for research an… |
10 mg |
11221-10 |
More Info
|
2-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; intended for research an… |
5 mg |
11221-5 |
More Info
|
2-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; intended for research an… |
50 mg |
11221-50 |
More Info
|
3-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; regulated as a Schedule… |
10 mg |
11222-10 |
More Info
|
3-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; regulated as a Schedule… |
5 mg |
11222-5 |
More Info
|
3-Methylethcathinone (hydrochloride) |
A substituted cathinone with potential for abuse; regulated as a Schedule… |
50 mg |
11222-50 |
More Info
|
4-Methylethcathinone (hydrochloride) |
A cathinone derivative identified in several designer drugs that are sold… |
10 mg |
9001069-10 |
More Info
|
4-Methylethcathinone (hydrochloride) |
A cathinone derivative identified in several designer drugs that are sold… |
5 mg |
9001069-5 |
More Info
|
4-Methylethcathinone (hydrochloride) |
A cathinone derivative identified in several designer drugs that are sold… |
50 mg |
9001069-50 |
More Info
|
4-Methylethcathinone (hydrochloride) (exempt preparation) |
A cathinone derivative identified in several designer drugs that are sold… |
1 mg |
16049-1 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) |
A metabolite of 4-MEC that features conversion of the β-keto group to… |
1 mg |
14758-1 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) |
A metabolite of 4-MEC that features conversion of the β-keto group to… |
5 mg |
14758-5 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) |
A metabolite of 4-MEC that features conversion of the β-keto group to… |
500 µg |
14758-500 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 4-methylethcathinone that features conversion of the &beta… |
1 mg |
9001436-1 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 4-methylethcathinone that features conversion of the &beta… |
5 mg |
9001436-5 |
More Info
|
4-Methylethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 4-methylethcathinone that features conversion of the &beta… |
500 µg |
9001436-500 |
More Info
|
5-methyl Etodesnitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
36767-1 |
More Info
|